Authors: Xue, CB He, XH Corbett, RL Roderick, J Wasserman, ZR Liu, RQ Jaffee, BD Covington, MB Qian, MX Trzaskos, JM Newton, RC Magolda, RL Wexler, RR Decicco, CP

Citation: Cb. Xue et al., Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1 ', a series of selective TNF-alpha converting enzyme inhibitorswith potent cellular activity in the inhibition of TNF-alpha release, J MED CHEM, 44(21), 2001, pp. 3351-3354

Authors: Xue, CB Voss, ME Nelson, DJ Duan, JJW Cherney, RJ Jacobson, IC He, XH Roderick, J Chen, LH Corbett, RL Wang, L Meyer, DT Kennedy, K DeGrado, WF Hardman, KD Teleha, CA Jaffee, BD Liu, RQ Copeland, RA Covington, MB Christ, DD Trzaskos, JM Newton, RC Magolda, RL Wexler, RR Decicco, CP

Citation: Cb. Xue et al., Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro andin vivo, J MED CHEM, 44(16), 2001, pp. 2636-2660

Authors: Jaffee, BD Manos, EJ Collins, RJ Czerniak, PM Favata, MF Magolda, RL Scherle, PA Trzaskos, JM

Citation: Bd. Jaffee et al., Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo, BIOC BIOP R, 268(2), 2000, pp. 647-651

Authors: Cherney, RJ Wang, L Meyer, DT Xue, CB Arner, EC Copeland, RA Covington, MB Hardman, KD Wasserman, ZR Jaffee, BD Decicco, CP

Citation: Rj. Cherney et al., Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production, BIOORG MED, 9(9), 1999, pp. 1279-1284